Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Financing Cash Flow
$32.24M
TTM · Period ending: · USD
LCTX Financing Cash Flow
Latest reported$32.24Mperiod ending
Latest reported$32.24Mperiod ending
LCTX Cash from Financing ($5.30M → $32.24M)
Annual financing cash flow
High-resolution chart · PNG
LCTX financing cash flow history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 26,950,000 | |
| 35,857,000 | |
| 6,423,000 | |
| 1,632,000 | |
| 36,930,000 | |
| 29,865,000 | |
| 617,000 | |
| 5,774,000 | |
| 55,391,000 | |
| 32,782,000 | |
| 64,775,000 | |
| 63,623,243 | |
| 34,263,608 | |
| 1,913,378 | |
| 3,862,414 | |
| 25,767,456 | |
| 16,482,966 | |
| 2,516,895 | |
| 694,937 | |
| 126 | |
| 1,877,160 | |
| 2,190,274 | |
| 86,896 | |
| 1,764,670 | |
| 3,549,360 | |
| 915,964 | |
| 7,420,412 | |
| 400,000 | |
| 6,700,000 | |
| 1,100,000 | |
| -200,000 | |
| 3,900,000 | |
| -100,000 | |
| 5,300,000 |